Multiple sclerosis patients taking glucagon-like peptide-1 receptor (GLP-1) agonists: a single-institution retrospective cohort study of tolerability and weight loss
The Centers for Disease Control and Prevention (CDC) reports that excessive alcohol use, which includes rapid drinking, leads to 178,000 deaths annually in the United States, highlighting the severe consequences of this behavior
DOI: 10.1177/2050313X221084839
The unglamorous answer is a calorie intake at or slightly above maintenance, a high protein target, and eighteen months of real strength training
Ozempic is a GLP-1 receptor agonist, while retatrutide is a triple-hormone receptor agonist, targeting GIP, GLP-1, and GCG simultaneously